(+/-)-trans-3-(4-methylphenyl)glycidic acid | 81476-88-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (+/-)-trans-3-(4-methylphenyl)glycidic acid
• 英文别名: 3-(4-Methylphenyl)oxirane-2-carboxylic acid
• CAS: 81476-88-2
• 化学式: C₁₀H₁₀O₃
• 分子量: 178.188
• InChiKey: KYFKCKUXXZSOTF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  49.8
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  4-methylcinnamic acid 在 12-alpha-羟基-3-氧代-5-beta-胆烷酸 Oxone 、 乙二胺四乙酸 、 碳酸氢钠 作用下， 以 水 为溶剂， 反应 2.0h， 生成 (+/-)-trans-3-(4-methylphenyl)glycidic acid 、 (+/-)-trans-3-(4-methylphenyl)glycidic acid
  参考文献：
  名称：

  Improved Enantioselectivity in the Epoxidation of Cinnamic Acid Derivatives with Dioxiranes from Keto Bile Acids

  摘要：

  The asymmetric epoxidation of substituted cinnamic acids has been obtained in the presence of different keto bile acid derivatives as optically active carbonyl inducers and Oxone as oxygen source. Predominant or almost exclusive formation of both enantiomeric epoxides is obtained (ee up to 95%) depending on the specific substitution at carbons C(7) and C(12) of the bile acid.

  DOI：

  10.1021/jo020146b

文献信息

• Novel 1,5-benzothiazepine derivative, processes for preparing the same and pharmaceutical compositions
  申请人：Tanabe Seiyaku Co., Ltd.

  公开号：EP0158340A2

  公开（公告）日：1985-10-16

  Novel 1,5-benzothiazepine derivatives of the formula: wherein R' and R4 are: a) R1 is lower alkyl or lower alkoxy, and R4 is lower alkyl, lower alkoxy, fluorine, benzyloxy, hydroxy or lower alkylthio, or b) R' is lower alkyl, and R4 is hydrogen, or c) R' is hydroxy, and R4 is lower alkyl, fluorine, hydroxy or lower alkylthio; R2 is hydrogen, lower alkanoyl or benzoyl; and R3 is lower alkyl; and a pharmaceutically acceptable acid addition salt thereof are disclosed. In form of pharmaceutical compositions the said derivative (I) and its salt have a potent platelet aggregation-inhibiting activity.

  式中的新型 1，5-苯并硫氮杂卓衍生物： 其中 R' 和 R4 是 a) R1 是低级烷基或低级烷氧基，R4 是低级烷基、低级烷氧基、氟、苄氧基、羟基或低级烷硫基，或 b) R' 是低级烷基，R4 是氢，或 c) R' 是羟基，R4 是低级烷基、氟、羟基或低级烷硫基； R2 是氢、低级烷酰基或苯甲酰基；R3 是低级烷基；及其药学上可接受的酸加成盐。在药物组合物中，上述衍生物（I）及其盐具有强效的血小板聚集抑制活性。
• Asymmetric epoxidation of cinnamic acid derivatives using dioxiranes generated in situ from dehydrocholic acid
  作者：Olga Bortolini、Marco Fogagnolo、Giancarlo Fantin、Silvia Maietti、Alessandro Medici

  DOI：10.1016/s0957-4166(01)00192-6

  日期：2001.5

  The asymmetric epoxidation of different cinnamic acid derivatives in water-NaHCO3 has been achieved using dehydrocholic acid as the optically active ketone and Oxone((R)) as the oxygen sourer: (with product e.e. values of up to 75%). (C) 2001 Elsevier Science Ltd. All rights: reserved.
• Process for preparing optically active 3-phenylglycidic acid esters
  申请人：TANABE SEIYAKU CO., LTD.

  公开号：EP0528607B1

  公开（公告）日：1997-04-23
• JPH00568588A
  申请人：——

  公开号：JPH00568588A

  公开（公告）日：1993-03-23
• JPH0568588A
  申请人：——

  公开号：JPH0568588A

  公开（公告）日：1993-03-23